Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Compass Therapeutics Inc (NASDAQ: CMPX) was $1.50 for the day, down -0.66% from the previous closing price of $1.51. In other words, the price has decreased by -$0.66 from its previous closing price. On the day, 0.13 million shares were traded. CMPX stock price reached its highest trading level at $1.524 during the session, while it also had its lowest trading level at $1.47.
Ratios:
Our analysis of CMPX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 31.84 and its Current Ratio is at 31.84. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on December 23, 2024, initiated with a Buy rating and assigned the stock a target price of $32.
On November 15, 2024, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform and also lowered its target price recommendation from $5 to $4.
Ladenburg Thalmann Upgraded its Neutral to Buy on September 16, 2024, while the target price for the stock was maintained at $5.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMPX now has a Market Capitalization of 206383488 and an Enterprise Value of 61348056. For the stock, the TTM Price-to-Sale (P/S) ratio is 242.80 while its Price-to-Book (P/B) ratio in mrq is 1.49. Its current Enterprise Value per Revenue stands at 72.174 whereas that against EBITDA is -1.119.
Stock Price History:
Over the past 52 weeks, CMPX has reached a high of $2.34, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is -8.27%, while the 200-Day Moving Average is calculated to be 0.14%.
Shares Statistics:
CMPX traded an average of 486.68K shares per day over the past three months and 391860 shares per day over the past ten days. A total of 137.59M shares are outstanding, with a floating share count of 84.48M. Insiders hold about 38.60% of the company’s shares, while institutions hold 39.08% stake in the company. Shares short for CMPX as of 1732838400 were 1451920 with a Short Ratio of 2.98, compared to 1730332800 on 1786958. Therefore, it implies a Short% of Shares Outstanding of 1451920 and a Short% of Float of 1.49.
